よむ、つかう、まなぶ。
「日本人の食事摂取基準（2025年版）」策定検討会報告書 (289 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_44138.html |
| 出典情報 | 「日本人の食事摂取基準（2025年版）」策定検討会報告書（10／11）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
149) Oenning LL, Vogel J, Calvo MS. Accuracy of methods estimating calcium and phosphorus intake in daily
diets. J Am Diet Assoc. 1988;88(9):1076-1080.
150) 食品安全委員会. 食品添加物のばく露評価に関する情報収集調査. 2023.
https://www.fsc.go.jp/fsciis/survey/show/cho20230020001
151) 厚生労働省. 令和 3 年度マーケットバスケット方式による酸化防止剤、防かび剤等の摂取量調査
の結果について. 2023. https://www.mhlw.go.jp/content/001071931.pdf
152) 石田淳子, 加藤明彦. 日本人の食事によるリン摂取量―透析患者も含めて―. 日本透析医会雑誌.
2016;30(3):512-518.
153) Institute of Medicine. Phosphorus. In: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium,
Vitamin D, and Fluoride. National Academies Press, Washington, D.C.; 1997:146-189.
154) 奥田豊子, 西村(三好)弘子, 松平敏子, 他. 高齢者におけるカルシウム、リン、マグネシウムの吸
収率と出納. 栄養学雑誌. 1995;53(1):33-40.
155) Fomon SJ, Haschke F, Ziegler EE, et al. Body composition of reference children from birth to age 10 years.
Am J Clin Nutr. 1982;35(5 Suppl):1169-1175.
156) Bell RR, Draper HH, Tzeng DY, et al. Physiological responses of human adults to foods containing
phosphate additives. J Nutr. 1977;107(1):42-50.
157) Calvo MS, Heath H 3rd. Acute effects of oral phosphate-salt ingestion on serum phosphorus, serum ionized
calcium, and parathyroid hormone in young adults. Am J Clin Nutr. 1988;47(6):1025-1029.
158) Silverberg SJ, Shane E, Clemens TL, et al. The effect of oral phosphate administration on major indices of
skeletal metabolism in normal subjects. J Bone Miner Res. 1986;1(4):383-388.
159) Nishida Y, Taketani Y, Yamanaka-Okumura H, et al. Acute effect of oral phosphate loading on serum
fibroblast growth factor 23 levels in healthy men. Kidney Int. 2006;70(12):2141-2147.
160) Zemel MB, Linkswiler HM. Calcium metabolism in the young adult male as affected by level and form of
phosphorus intake and level of calcium intake. J Nutr. 1981;111(2):315-324.
161) Kemi VE, Kärkkäinen MUM, Lamberg-Allardt CJE. High phosphorus intakes acutely and negatively affect
Ca and bone metabolism in a dose-dependent manner in healthy young females. Br J Nutr. 2006;96(3):545552.
162) Vervloet MG, van Ittersum FJ, Büttler RM, et al. Effects of dietary phosphate and calcium intake on
fibroblast growth factor-23. Clin J Am Soc Nephrol. 2011;6(2):383-389.
163) Ferrari SL, Bonjour JP, Rizzoli R. Fibroblast growth factor-23 relationship to dietary phosphate and renal
phosphate handling in healthy young men. J Clin Endocrinol Metab. 2005;90(3):1519-1524.
164) Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23
concentrations in healthy men. J Clin Endocrinol Metab. 2006;91(8):3144-3149.
165) Burnett SAM, Gunawardene SC, Bringhurst FR, et al. Regulation of C-terminal and intact FGF-23 by
dietary phosphate in men and women. J Bone Miner Res. 2006;21(8):1187-1196.
166) Sigrist M, Tang M, Beaulieu M, et al. Responsiveness of FGF-23 and mineral metabolism to altered dietary
phosphate intake in chronic kidney disease (CKD): results of a randomized trial. Nephrol Dial Transplant.
2013;28(1):161-169.
167) Mirza MAI, Larsson A, Lind L, et al. Circulating fibroblast growth factor-23 is associated with vascular
dysfunction in the community. Atherosclerosis. 2009;205(2):385-390.
279
diets. J Am Diet Assoc. 1988;88(9):1076-1080.
150) 食品安全委員会. 食品添加物のばく露評価に関する情報収集調査. 2023.
https://www.fsc.go.jp/fsciis/survey/show/cho20230020001
151) 厚生労働省. 令和 3 年度マーケットバスケット方式による酸化防止剤、防かび剤等の摂取量調査
の結果について. 2023. https://www.mhlw.go.jp/content/001071931.pdf
152) 石田淳子, 加藤明彦. 日本人の食事によるリン摂取量―透析患者も含めて―. 日本透析医会雑誌.
2016;30(3):512-518.
153) Institute of Medicine. Phosphorus. In: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium,
Vitamin D, and Fluoride. National Academies Press, Washington, D.C.; 1997:146-189.
154) 奥田豊子, 西村(三好)弘子, 松平敏子, 他. 高齢者におけるカルシウム、リン、マグネシウムの吸
収率と出納. 栄養学雑誌. 1995;53(1):33-40.
155) Fomon SJ, Haschke F, Ziegler EE, et al. Body composition of reference children from birth to age 10 years.
Am J Clin Nutr. 1982;35(5 Suppl):1169-1175.
156) Bell RR, Draper HH, Tzeng DY, et al. Physiological responses of human adults to foods containing
phosphate additives. J Nutr. 1977;107(1):42-50.
157) Calvo MS, Heath H 3rd. Acute effects of oral phosphate-salt ingestion on serum phosphorus, serum ionized
calcium, and parathyroid hormone in young adults. Am J Clin Nutr. 1988;47(6):1025-1029.
158) Silverberg SJ, Shane E, Clemens TL, et al. The effect of oral phosphate administration on major indices of
skeletal metabolism in normal subjects. J Bone Miner Res. 1986;1(4):383-388.
159) Nishida Y, Taketani Y, Yamanaka-Okumura H, et al. Acute effect of oral phosphate loading on serum
fibroblast growth factor 23 levels in healthy men. Kidney Int. 2006;70(12):2141-2147.
160) Zemel MB, Linkswiler HM. Calcium metabolism in the young adult male as affected by level and form of
phosphorus intake and level of calcium intake. J Nutr. 1981;111(2):315-324.
161) Kemi VE, Kärkkäinen MUM, Lamberg-Allardt CJE. High phosphorus intakes acutely and negatively affect
Ca and bone metabolism in a dose-dependent manner in healthy young females. Br J Nutr. 2006;96(3):545552.
162) Vervloet MG, van Ittersum FJ, Büttler RM, et al. Effects of dietary phosphate and calcium intake on
fibroblast growth factor-23. Clin J Am Soc Nephrol. 2011;6(2):383-389.
163) Ferrari SL, Bonjour JP, Rizzoli R. Fibroblast growth factor-23 relationship to dietary phosphate and renal
phosphate handling in healthy young men. J Clin Endocrinol Metab. 2005;90(3):1519-1524.
164) Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23
concentrations in healthy men. J Clin Endocrinol Metab. 2006;91(8):3144-3149.
165) Burnett SAM, Gunawardene SC, Bringhurst FR, et al. Regulation of C-terminal and intact FGF-23 by
dietary phosphate in men and women. J Bone Miner Res. 2006;21(8):1187-1196.
166) Sigrist M, Tang M, Beaulieu M, et al. Responsiveness of FGF-23 and mineral metabolism to altered dietary
phosphate intake in chronic kidney disease (CKD): results of a randomized trial. Nephrol Dial Transplant.
2013;28(1):161-169.
167) Mirza MAI, Larsson A, Lind L, et al. Circulating fibroblast growth factor-23 is associated with vascular
dysfunction in the community. Atherosclerosis. 2009;205(2):385-390.
279